Beginning with lung diseases, Ebenbuild serves patients suffering from severe illnesses. The company maximizes health through unprecedented computational models that enable better and more efficient healthcare. Based on scientific knowledge of physics, physiology, biochemistry, and disease mechanisms, Ebenbuild creates ground-breaking, personalized, predictive digital twins. Personalized medicine here means understanding the individual first and then deriving empirical insights.

Ebenbuild's digital twin platform connects industries within healthcare and life sciences. Their technology aims to maximize patient benefit by informing efficient and effective treatment decisions in hospitals, optimizing drug delivery to the lungs, and tracking respiratory disease progression. Ebenbuild provides digital tools for precise decision-making to clinical and industrial users.